It's been only five years since the FDA approved the first medication for hidradenitis, but more options are on the way.
Christopher Sayed, M.D., associate professor of dermatology at the University of North Carolina at Chapel Hill, discusses some of the new, exciting treatments for HS, including biologics.
In general, it's an exciting time in HS, in terms of the different types of medications that are being developed. There are at least 10 drugs in clinical trials right now.
These are drugs that are often available on the market already for conditions like psoriasis or inflammatory bowel disease. They're in trials now for hidradenitis, in particular. Then there are a lot of newer drugs that aren’t on the market yet for anything that are being developed for HS, too, which is exciting.